Cargando…

Severe Hypocalcemia and Hypomagnesemia with Denosumab in Advanced Chronic Kidney Disease: Case Report and Literature Review

BACKGROUND: Denosumab has become the preferred agent over zolendronic acid to help prevent skeletal-related events in patients with metastatic bone disease and multiple myeloma because it is approved for use in those with kidney dysfunction. However, denosumab has been linked to cases of hypocalcemi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marlow, Christina F., Sharma, Shailendra, Babar, Faizan, Lin, Jianqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204163/ https://www.ncbi.nlm.nih.gov/pubmed/30405927 http://dx.doi.org/10.1155/2018/2059364

Ejemplares similares

Association of Hypomagnesemia with Hypocalcemia after Thyroidectomy
por: Chincholikar, Shrikanth P., et al.
Publicado: (2018)

Famotidine induced hypomagnesemia leading to hypocalcemia
por: Essrani, Rajesh, et al.
Publicado: (2020)

Severe Refractory Hypocalcemia Caused by Denosumab
por: Dadana, Sriharsha, et al.
Publicado: (2023)

Hypocalcemia secondary to hypomagnesemia in a patient on liraglutide
por: Habnouny, J.E.L., et al.
Publicado: (2020)

Familial Hypomagnesemia With Secondary Hypocalcemia: A Case Report
por: Gazzaz, Nour, et al.
Publicado: (2021)

SAT229 Symptomatic Hypocalcemia In The Setting Of Crohn’s Disease With Severe Hypomagnesemia
por: Cuan, Katherine, et al.
Publicado: (2023)

Severe hypocalcemia after denosumab administration in a patient with chronic kidney disease: a case report
por: Kouroglou, Eleni, et al.
Publicado: (2023)

Hypomagnesemia predicts postoperative biochemical hypocalcemia after thyroidectomy
por: Luo, Han, et al.
Publicado: (2017)

Familial Hypomagnesemia with Secondary Hypocalcemia Presenting as Refractory Seizures
por: Pandey, Amit Kumar, et al.
Publicado: (2023)

Severe Hypocalcemia due to Denosumab in Metastatic Prostate Cancer
por: Muqeet Adnan, Mohammed, et al.
Publicado: (2014)

Prolonged Hypocalcemia After a Single Dose of Denosumab in Chronic Kidney Disease
por: Puar, Akshan, et al.
Publicado: (2021)

Two unusual cases of severe recalcitrant hypocalcemia due to aminoglycoside-induced hypomagnesemia
por: Varma, Tarun, et al.
Publicado: (2013)

Imaging findings in TRPM6-Related hypomagnesemia with secondary hypocalcemia
por: Malik, Prateek, et al.
Publicado: (2021)

Denosumab Induced Severe Prolonged Hypocalcemia in Metastatic Prostate Cancer
por: Mehmood, Hassan, et al.
Publicado: (2021)

Proton-pump Inhibitor-induced Severe Hypomagnesemia and Hypocalcemia are Clinically Masked by Thiazide Diuretic
por: Uehara, Atsuko, et al.
Publicado: (2019)

Integrated Osteoporosis Care to Reduce Denosumab-Associated Hypocalcemia for Patients with Advanced Chronic Kidney Disease and End-Stage Renal Disease
por: Hsu, Chia-Tien, et al.
Publicado: (2023)

Severe, Symptomatic Hypocalcemia due to Denosumab Administration: Treatment and Clinical Course
por: Strickling, Jarred, et al.
Publicado: (2019)

Denosumab Induced Severe Hypocalcemia in a Patient With Metastatic Prostate Cancer
por: Naher, Kamrun, et al.
Publicado: (2021)

Long-term Clinical Follow-up of Patients with Familial Hypomagnesemia with Secondary Hypocalcemia
por: Bayramoğlu, Elvan, et al.
Publicado: (2021)

The Calcium Culprit: A Case of Denosumab-induced Hypocalcemia
por: Kalayanamitra, Ricci, et al.
Publicado: (2019)

An old friend turned foe: Metformin‐induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia
por: Sharma, Avirale, et al.
Publicado: (2021)

Severe hypocalcemia following a single injection of denosumab in a patient with renal impairment
por: Talreja, Draupadi B.
Publicado: (2012)

Denosumab-induced hypocalcemia in a patient with hyperthyroidism: a case report
por: Park, S.Y., et al.
Publicado: (2021)

PSAT189 Severe Hypocalcemia and Hypophosphatemia Associated with Denosumab use in a Chronic Myeloid Leukemia Patient on Imatinib
por: Shah, Tanvi, et al.
Publicado: (2022)

Severe Hypocalcemia and Dramatic Increase in Parathyroid Hormone after Denosumab in a Dialysis Patient: A Case Report and Review of the Literature
por: Bhanot, Ravinder D., et al.
Publicado: (2019)

Denosumab-induced hypocalcemia post bariatric surgery—a severe and protracted course: a case report
por: Awang, Mohd Hazriq, et al.
Publicado: (2023)

Case Report: Novel TRPM6 Mutations Cause Hereditary Hypomagnesemia With Secondary Hypocalcemia in a Chinese Family and a Literature Review
por: Han, Yiran, et al.
Publicado: (2022)

Denosumab-Induced Hypocalcemia after Billroth II Gastric Bypass Surgery
por: Schmucker, Abigail M., et al.
Publicado: (2020)

Hypocalcemia in a Patient With Metastatic Prostate Cancer From Denosumab Treatment
por: Gouli, Sugam, et al.
Publicado: (2021)

A novel TRPM6 variant (c.3179T>A) causing familial hypomagnesemia with secondary hypocalcemia
por: Lomelino-Pinheiro, Sara, et al.
Publicado: (2020)

The Effect of Hypomagnesemia on Refractory Hypocalcemia after Total Thyroidectomy: A Single-Center Prospective Cohort Study
por: Karunakaran, Poongkodi, et al.
Publicado: (2020)

SAT-512 Severe Hypocalcemia Presenting as Status Epilepticus after Denosumab Use in Metastatic Prostate Cancer
por: Saeed, Zeb, et al.
Publicado: (2019)

Denosumab-Induced Severe Hypocalcaemia in Chronic Kidney Disease
por: Jalleh, Ryan, et al.
Publicado: (2018)

Diagnosis and Management of Denosumab-Induced Hypocalcemia and Hypophosphatemia in the Setting of Metastatic Prostate Cancer
por: Flood, Michael G, et al.
Publicado: (2022)

Hypomagnesemia-Induced Hypocalcemia Successfully Treated With Sodium-Glucose Cotransport Inhibitor (SGLT-2i), a Case Report
por: Gandhi, Anand, et al.
Publicado: (2021)

SAT-365 Severe, Symptomatic Hypocalcemia Due to Denosumab and Vitamin D Deficiency in an Osteopenic Post-Menopausal Female
por: Berquist, John, et al.
Publicado: (2020)

Hypomagnesemia-Induced Seizures Post Severe Acute Kidney Injury
por: AL-Omairi, Anwar, et al.
Publicado: (2022)

High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis
por: Ishikawa, Koji, et al.
Publicado: (2016)

SAT228 Denosumab Associated Severe Hypocalcemia Due To Vitamin D Deficiency In A Patient With Undiagnosed Primary Hyperparathyroidism
por: Reddy Bendaram, Snigdha, et al.
Publicado: (2023)

Hereditary kidney diseases associated with hypomagnesemia
por: Claverie-Martin, Felix, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tnd0epr85qivn35dr79fuf3746